Combined Statement of Operations Sample Clauses

Combined Statement of Operations a. Represents purchase price adjustments for the acquisition of 3PD as follows:
Sample 1Sample 2
AutoNDA by SimpleDocs
Combined Statement of Operations. For the Year Ended December 31, 2019 (In thousands, except share and per share data) Sonnet BioTherapeutics, Inc. Year ended September 30, 2019 Relief Therapeutics SA Pro Forma Adjustments Notes Pro Forma Sonnet BioTherapeutics, Inc. Chanticleer Holdings, Inc. Pro Forma Adjustments Notes Pro Forma Combined Revenues $ — $ — $ — $ — $ 30,143 $ (30,143 ) F $ — Costs and expenses: Cost of revenues — — — — 29,263 (29,263 ) F — Research and development 2,199 39 — 2,238 — — 2,238 Selling, general and administrative 2,509 196 (107 ) K 2,598 5,966 (5,966 ) M 2,598 Asset impairment charge — — — — 9,150 (9,150 ) F — Depreciation and amortization — 1 (1 ) L — 1,842 (1,842 ) F — Total costs and expenses 4,708 236 (108 ) 4,836 46,221 (46,221 ) 4,836 Loss from operations (4,708 ) (236 ) 108 (4,836 ) (16,078 ) 16,078 (4,836 ) Interest expense (163 ) — — (163 ) (674 ) 674 F (163 ) Other income (expense) — 1,507 — 1,507 (617 ) 617 F 1,507 Total other income (expenses) (163 ) 1,507 — 1,344 (1,291 ) 1,291 1,344 Loss before income taxes (4,871 ) 1,271 108 (3,492 ) (17,369 ) 17,369 (3,492 ) Income tax benefit (expense) — (10 ) — (10 ) (74 ) 74 F (10 ) Net loss $ (4,871 ) $ 1,261 $ 108 $ (3,502 ) $ (17,443 ) $ 17,443 $ (3,502 ) Net loss attributable to noncontrolling interests — — — — 402 (402 ) F — Net loss attributable to the company $ (4,871 ) $ 1,261 $ 108 $ (3,502 ) $ (17,041 ) $ 17,041 $ (3,502 ) Dividends on redeemable preferred stock — — — — (112 ) 112 F — Net loss attributable to common stockholders $ (4,871 ) $ 1,261 $ 108 $ (3,502 ) $ (17,153 ) $ 17,153 $ (3,502 ) Net loss per share, basic and diluted $ (2.43 ) $ (1.55 ) $ (63.90 ) $ (0.39 ) Weighted average common shares outstanding, basic and diluted 2,002,125 N 2,275,661 268,417 O 9,001,825 Notes to the Unaudited Pro Forma Condensed Combined Financial Statements
Sample 1
Combined Statement of Operations. For the Three Months Ended December 31, 2019 (In thousands, except share and per share data) Sonnet BioTherapeutics, Inc. Relief Therapeutics SA Pro Forma Adjustments Notes Pro Forma Combined Costs and expenses: Research and development $ 1,408 $ 10 $ — $ 1,418 Selling, general and administrative 1,061 112 (231 ) H 942 Total costs and expenses 2,469 122 (231 ) 2,360 Loss from operations (2,469 ) (122 ) 231 (2,360 ) Other income (expense) — 133 — 133 Total other income (expenses) — 133 — 133 (Loss) income before taxes (2,469 ) 11 231 (2,227 ) Income tax expense — (10 ) — (10 ) Net (loss) income $ (2,469 ) $ 1 $ 231 $ (2,237 ) Net loss per share, basic and diluted $ (1.22 ) $ (0.25 ) Weighted average common shares outstanding, basic and diluted 2,018,095 J,K 9,105,218 Unaudited Pro Forma Condensed Combined Statement of Operations For the Year Ended September 30, 2019 (In thousands, except share and per share data) Sonnet BioTherapeutics, Inc. Relief Therapeutics SA Pro Forma Adjustments Notes Pro Forma Combined Costs and expenses: Research and development $ 2,199 $ 68 $ — $ 2,267 Selling, general and administrative 2,509 81 (177 ) H 2,413 Depreciation and amortization — 3 (3 ) I — Total costs and expenses 4,708 152 (180 ) 4,680 Loss from operations (4,708 ) (152 ) 180 (4,680 ) Interest expense (163 ) — — (163 ) Other income (expense) — 1,379 — 1,379 Total other income (expenses) (163 ) 1,379 — 1,216 Net loss $ (4,871 ) $ 1,227 $ 180 $ (3,464 ) Net loss per share, basic and diluted $ (2.52 ) $ (0.38 ) Weighted average common shares outstanding, basic and diluted 1,931,396 J,K 9,001,825 Notes to the Unaudited Pro Forma Condensed Combined Financial Statements
Sample 1
Combined Statement of Operations a. Represents purchase price adjustments for the merger with Pacer as follows:
Sample 1
Combined Statement of Operations. For the Nine Months Ended June 30, 2021 (in thousands, except per share amounts) Xxxxx ELFS Pro forma Adjustments Pro forma Combined Revenue $ 91,446 $ 54,542 $ - $ 145,988 Forwarding expenses and cost of revenues 68,680 39,251 - 107,931 Gross profit 22,766 15,291 - 38,057 Selling, general and administrative expenses 19,282 12,846 - 32,128 Amortization of intangible assets 832 - 427 6a 1,259 Total Costs and Expenses 20,114 12,846 427 33,387 Income from operations 2,652 2,445 (427 ) 4,670 Interest expense net of interest income (418 ) (59 ) (417 ) 6b (894 ) Gain on Paycheck Protection Program loan forgiveness 135 - - 135 Income Before Income Taxes 2,369 2,386 (844 ) 3,911 Income tax benefit (expense) (648 ) (124 ) (379 ) 6c (1,151 ) Net Income 1,721 2,262 (1,223 ) 2,760 Preferred stock dividends (566 ) - - (566 ) Net Available to Common Stockholders $ 1,155 $ 2,262 $ (1,223 ) $ 2,194 Net Income per share: Basic $ 1.84 $ - $ - $ 2.95 Diluted $ 1.75 $ - $ - $ 2.81 Net per share attributable to common stockholders: Basic $ 1.24 $ - $ - $ 2.34 Diluted $ 1.17 $ - $ - $ 2.23 Weighted average number of shares: Basic 936,154 - - 936,154 Diluted 983,784 - - 983,784 See the accompanying notes to the unaudited pro forma combined financial statements which are an integral part of these financial statements. Xxxxx Corporation
Sample 1

Related to Combined Statement of Operations

  • Statement of Operations d. Statement of Changes in Net Assets.

  • Control of Operations Without in any way limiting any party’s rights or obligations under this Agreement, the parties understand and agree that (a) nothing contained in this Agreement shall give Parent or the Company, directly or indirectly, the right to control or direct the other party’s operations prior to the Effective Time and (b) prior to the Effective Time, each of the Company and Parent shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its operations.

  • Cessation of Operations Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its debts as such debts become due, provided, however, that any disclosure of the Borrower’s ability to continue as a “going concern” shall not be an admission that the Borrower cannot pay its debts as they become due.

  • Continuity of Operations (1) Engage in any business activities substantially different than those in which Borrower is presently engaged, (2) cease operations, liquidate, merge, transfer, acquire or consolidate with any other entity, change its name, dissolve or transfer or sell Collateral out of the ordinary course of business, or (3) pay any dividends on Borrower's stock (other than dividends payable in its stock), provided, however that notwithstanding the foregoing, but only so long as no Event of Default has occurred and is continuing or would result from the payment of dividends, if Borrower is a "Subchapter S Corporation" (as defined in the Internal Revenue Code of 1986, as amended), Borrower may pay cash dividends on its stock to its shareholders from time to time in amounts necessary to enable the shareholders to pay income taxes and make estimated income tax payments to satisfy their liabilities under federal and state law which arise solely from their status as Shareholders of a Subchapter S Corporation because of their ownership of shares of Borrower's stock, or purchase or retire any of Borrower's outstanding shares or alter or amend Borrower's capital structure.

  • Hours of Operation Account Processing Services will be available for use by Client during standard Fiserv business hours, excluding holidays, as specified in Exhibit A - 3. Account Processing Services may be available during additional hours, during which time Client may use Services at its option and subject to additional charges.

  • Financial Statements; Non-GAAP Financial Measures The financial statements included or incorporated by reference in the Registration Statement and the Prospectus, together with the related schedules and notes, present fairly in all material respects the consolidated financial position of the Company and the respective entities to which such financial statements relate (the “Covered Entities”) at the dates indicated and the consolidated statements of operations, stockholders’ equity (deficit) and cash flows of the Covered Entities for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout the periods involved. The supporting schedules, if any, present fairly in all material respects in accordance with GAAP the information required to be stated therein. The selected financial data and the summary financial information included in the Registration Statement and the Prospectus present fairly in all material respects the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included therein. Any pro forma financial statements and the related notes thereto included in the Registration Statement and the Prospectus present fairly in all material respects the information shown therein, have been prepared in accordance with the Commission’s rules and guidelines with respect to pro forma financial statements and have been properly compiled on the bases described therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein. Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement or the Prospectus under the Securities Act. All disclosures contained in the Registration Statement or the Prospectus, or incorporated by reference, regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. The interactive data in Inline eXtensible Business Reporting Language incorporated by reference in the Registration Statement and the Prospectus, if any, fairly present the information called for in all material respects and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto.

  • Conduct of Operations The Board of Directors and the General Partner shall use commercially reasonable efforts to conduct the business of the Partnership and its Affiliates in a manner that does not require a holder of Common Units to file a tax return in any jurisdiction with which the holder has no contact other than through ownership of Common Units.

  • Consolidated With reference to any term defined herein, that term as applied to the accounts of a Person and its Subsidiaries, determined on a consolidated basis in accordance with GAAP.

  • Financial Position The Borrower has heretofore furnished to the Lenders its consolidated balance sheet and statements of income, stockholders’ equity and cash flows as of and for (a) the fiscal years ended December 31, 2014 and 2013 reported on by Ernst & Young LLP, independent public accountants and (b) the six months ended June 30, 2015. Such financial statements present fairly, in all material respects, the financial position and results of operations and cash flows of the Borrower and its consolidated subsidiaries as of such dates and for such periods in accordance with GAAP, subject to year-end audit adjustments and the absence of footnotes in the case of the statements referred to in clause (b) above.

  • Financial Statements; Accountants’ Reports; Other Information The Guarantor shall keep and maintain at all times complete and accurate books of accounts and records in sufficient detail to correctly reflect all of the Guarantor’s financial transactions and assets. In addition, the Guarantor shall furnish, or cause to be furnished, to the Lender the following:

Time is Money Join Law Insider Premium to draft better contracts faster.